GlassScriptPhysician profile
Christopher J Schaffer
NPI 1205834959
$11,815.14
in general payments reported to CMS, 2019-2025
14 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,882 · 2020: $131 · 2021: $643 · 2022: $737 · 2023: $493 · 2024: $479 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $5,548.95 | 2019 | |
| Allergan, INC. | $4,161.76 | 2019-2022 | |
| Abbvie INC. | $760.03 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $344.64 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Sientra, INC. | $248.28 | 2019-2022 | |
| Merz North America, INC. | $208.19 | 2020-2022 | |
| Lumenis Be INC | $179.29 | 2024 | Optilight |
| Rti Surgical, INC | $140.54 | 2022 | |
| Revance Therapeutics, INC. | $99.90 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $36.80 | 2019-2024 | Dysport |
| Motiva USA, LLC | $26.06 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $24.12 | 2025 | |
| Integra Lifesciences Corporation | $22.67 | 2023 | Durasorb Monofilament Mesh |
| Eagle Pharmaceuticals, INC. | $13.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.